Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 12 No. 4 (2006)

Vol. 12 No. 4 (2006)

Published: 2006-07-01

Editorial

  • Editorial

    Neil Henderson
    • PDF

Article

  • Valuing biotechnology companies using the price earnings ratio

    Jacqueline Loh, Robert Brooks
    • PDF
  • An overview of trends in multilateral environmental agreements with an impact on biotechnology and research in Asia and the Pacific

    Frankie Keller, Darryl R J Macer
    • PDF
  • What you give is what you get: Investment in European biotechnology

    William Bains
    • PDF
  • Ticking time bomb: Poorly managed product safety

    Greg Meline, Chris Albani
    • PDF
  • Cancer remains the dominant disease target for biotech through to 2010

    Fleur Pijpers, Mark J Belsey
    • PDF

Legal and Regulatory Updates

  • Legal and regulatory update

    Gerry Kamstra, John Wilkinson
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust